EichorEICHOR
Study identifier: NCT07662122 Synced from ClinicalTrials.gov · August 04, 2026
● Recruiting

A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

Condition: Obesity · Overweight  ·  Sponsor: Boehringer Ingelheim

PhasePhase 2
Planned participants300
Who can joinAll sexes, 18 Years to 74 Years
Healthy volunteersNo

About this study

This study is open to adults between 18 and 74 years of age and who have a body mass index (BMI) of 30 kg/m2 or more, or a BMI of 27 kg/m2 or more and at least 1 health problem related to their weight. People who have previously not managed to lose weight by changing their diet can participate. People with type 2 diabetes cannot take part in this study. The purpose of this study is to find out whether a medicine called BI 3034701 helps people living with obesity or overweight to lose weight. This study has 7 groups of participants. Groups 1 to 6 get different doses of BI 3034701; Group 7 gets placebo. Placebo looks like BI 3034701 but does not contain any medicine. Every participant has more than an 80% chance of getting BI 3034701. Participants receive 2 injections of BI 3034701 or placebo under their skin for 42 weeks. In addition to the study medicine, all participants receive counselling to make changes to their diet and to exercise regularly. Participants are in the study for about 10 months. During this time, they visit the study site 15 times. The study doctors regularly measure the participants' body weight and take necessary laboratory tests. Participants also answer questions about their well-being and note their food intake and physical activity in diaries. The results will be compared between groups of participants to see whether the treatment works. The study doctors also regularly check participants' health and take note of any unwanted effects.

This description comes directly from the study's public registry record.

Talk to the study team

Boehringer Ingelheim  ·  1-800-243-0127  ·  clintriage.rdg@boehringer-ingelheim.com

Always discuss trial participation with your own doctor first.

Locations (66)

Cahaba Research, Inc. - Trussville LocationBirmingham, Alabama, United StatesRecruiting
Focus Clinical ResearchWest Hills, California, United StatesNot Yet Recruiting
CMR of Greater New Haven, LLCHamden, Connecticut, United StatesNot Yet Recruiting
Optimus U Corporation-Miami-69452Miami, Florida, United StatesRecruiting
Javara-Fayetteville-67354Fayetteville, Georgia, United StatesRecruiting
Monroe Biomedical Research - LouisvilleLouisville, Kentucky, United StatesNot Yet Recruiting
Arcturus Healthcare - Troy Internal Medicine Research DivisionTroy, Michigan, United StatesNot Yet Recruiting
StudyMetrix Research, LLCCity of Saint Peters, Missouri, United StatesRecruiting
Clinvest Research LLCSpringfield, Missouri, United StatesRecruiting
Centricity Research - Morehead CityMorehead City, North Carolina, United StatesRecruiting
Accellacare-Wilmington-67123Wilmington, North Carolina, United StatesRecruiting
Lillestol Research, LLCFargo, North Dakota, United StatesRecruiting

+ 54 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →